Home Knowledge Base Miele

Miele

No mentions found

This entity hasn't been tracked yet, or Iris is still building its knowledge base.

Related Articles from SNS

GSK to buy US cancer treatment firm Nuvalent for $10.6bn

British drugmaker’s new chief executive Luke Miels announces one of its biggest dealsBusiness live – latest updatesGSK’s new boss Luke Miels has struck one of the British drugmaker’s biggest deals, announcing the $10.6bn (£7.9bn) acquisition of a US cancer specialist with two-late stage medications. The FTSE 100 company is boosting its oncology portfolio by agreeing to buy Nuvalent, a Boston-based biotech that develops cancer drugs, including three for lung cancer. GSK will pay $124 a share...

The Guardian World 1d ago

GSK to buy US cancer treatment firm Nuvalent for $10.6bn

British drugmaker’s new chief executive Luke Miels announces one of its biggest dealsBusiness live – latest updatesGSK’s new boss Luke Miels has struck one of the British drugmaker’s biggest deals, announcing the $10.6bn (£7.9bn) acquisition of a US cancer specialist with two-late stage medications. The FTSE 100 company is boosting its oncology portfolio by agreeing to buy Nuvalent, a Boston-based biotech that develops cancer drugs, including three for lung cancer. GSK will pay $124 a share...

The Guardian UK 1d ago

GSK to buy US cancer treatment firm Nuvalent for $10.6bn

British drugmaker’s new chief executive Luke Miels announces one of its biggest dealsBusiness live – latest updatesGSK’s new boss Luke Miels has struck one of the British drugmaker’s biggest deals, announcing the $10.6bn (£7.9bn) acquisition of a US cancer specialist with two-late stage medications. The FTSE 100 company is boosting its oncology portfolio by agreeing to buy Nuvalent, a Boston-based biotech that develops cancer drugs, including three for lung cancer. GSK will pay $124 a share...

The Guardian Business 1d ago

UK's GSK to acquire U.S. drugmaker Nuvalent for $10.6 billion as pharma giants race to expand pipelines

U.K. pharmaceutical group GSK has entered an agreement to acquire U.S.-based drugmaker Nuvalent for $10.6 billion to bolster its lung cancer pipeline, in what would be the British drugmaker's largest acquisition in more than a decade. The all-cash deal values Nuvalent at about $124 per share, according to a GSK filing on Tuesday, representing a 40% premium to its last closing price. The Financial Times had reported the transaction earlier on Tuesday.

CNBC 1d ago

Nicola’s only crime was to love too much. And to not notice the Jaguar on the drive

Rather than being one of the shrewdest operators in British politics for a decade, it turns out Sturgeon was just too trustingYou know how it is. You wake up and look out the bedroom window.

The Guardian UK 10d ago

Nicola’s only crime was to love too much. And to not notice the Jaguar on the drive

Rather than being one of the shrewdest operators in British politics for a decade, it turns out Sturgeon was just too trustingYou know how it is. You wake up and look out the bedroom window.

The Guardian Politics 10d ago

Lowe’s Promo Codes and Deals: Up to $300 Off Appliances

Lowe’s Home Improvement grew the old-fashioned way, working its way up from a single, small, family-owned North Carolina general store founded in 1921. But the Lowe’s hardware store empire is plenty big these days. A tool-filled Lowe’s superstore is now about as big as a New York City block.

Wired 14h ago